Differences in DBA/1J and DBA/2J reveal lipid QTL genes
Stylianou et al.
J. Lipid Res. 2008;49:2402-2413.
ABSTRACT
| FULL TEXT
Lentiviral Transduction of ApoAI Into Hematopoietic Progenitor Cells and Macrophages: Applications to Cell Therapy of Atherosclerosis
Su et al.
Arterioscler. Thromb. Vasc. Bio. 2008;28:1439-1446.
ABSTRACT
| FULL TEXT
Relationship Between Biomarkers of Oxidized Low-Density Lipoprotein, Statin Therapy, Quantitative Coronary Angiography, and Atheroma Volume Observations From the REVERSAL (Reversal of Atherosclerosis with Aggressive Lipid Lowering) Study.
Choi et al.
J Am Coll Cardiol 2008;52:24-32.
ABSTRACT
| FULL TEXT
Niacin inhibits surface expression of ATP synthase {beta} chain in HepG2 cells: implications for raising HDL
Zhang et al.
J. Lipid Res. 2008;49:1195-1201.
ABSTRACT
| FULL TEXT
Apolipoprotein A-I mimetic peptide helix number and helix linker influence potentially anti-atherogenic properties
Wool et al.
J. Lipid Res. 2008;49:1268-1283.
ABSTRACT
| FULL TEXT
Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patients
Bloedon et al.
J. Lipid Res. 2008;49:1344-1352.
ABSTRACT
| FULL TEXT
Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels
Hausenloy and Yellon
Heart 2008;94:706-714.
ABSTRACT
| FULL TEXT
Comparison of Pioglitazone vs Glimepiride on Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes: The PERISCOPE Randomized Controlled Trial
Nissen et al.
JAMA 2008;299:1561-1573.
ABSTRACT
| FULL TEXT
Effect of Rimonabant on Progression of Atherosclerosis in Patients With Abdominal Obesity and Coronary Artery Disease: The STRADIVARIUS Randomized Controlled Trial
Nissen et al.
JAMA 2008;299:1547-1560.
ABSTRACT
| FULL TEXT
Exploiting Complexity and the Robustness of Network Architecture for Drug Discovery
Hellerstein
J. Pharmacol. Exp. Ther. 2008;325:1-9.
ABSTRACT
| FULL TEXT
Ultrasound imaging techniques for the evaluation of cardiovascular therapies
Kastelein and de Groot
Eur Heart J 2008;29:849-858.
ABSTRACT
| FULL TEXT
Dose-related effects of repeated ETC-216 (recombinant apolipoprotein A-I Milano/1-palmitoyl-2-oleoyl phosphatidylcholine complexes) administrations on rabbit lipid-rich soft plaques: in vivo assessment by intravascular ultrasound and magnetic resonance imaging.
Parolini et al.
J Am Coll Cardiol 2008;51:1098-1103.
ABSTRACT
| FULL TEXT
Rapid change in plaque size, composition, and molecular footprint after recombinant apolipoprotein A-I Milano (ETC-216) administration: magnetic resonance imaging study in an experimental model of atherosclerosis.
Ibanez et al.
J Am Coll Cardiol 2008;51:1104-1109.
ABSTRACT
| FULL TEXT
ApoA-I(Milano)/phospholipid complex: clinical implications of dose-response studies in rabbit atherosclerosis with intravascular ultrasound and magnetic resonance imaging.
Zhao and Brown
J Am Coll Cardiol 2008;51:1110-1111.
FULL TEXT
HDL-cholesterol modulation and its impact on the management of cardiovascular risk
Ferns and Keti
Ann Clin Biochem 2008;45:122-128.
ABSTRACT
| FULL TEXT
Anti-Inflammatory and Cardioprotective Activities of Synthetic High-Density Lipoprotein Containing Apolipoprotein A-I Mimetic Peptides
Gomaraschi et al.
J. Pharmacol. Exp. Ther. 2008;324:776-783.
ABSTRACT
| FULL TEXT
Publication of Clinical Trials in JAMA: Information for Authors
Fontanarosa and DeAngelis
JAMA 2008;299:95-96.
FULL TEXT
Structural requirements for antioxidative and anti-inflammatory properties of apolipoprotein A-I mimetic peptides
Anantharamaiah et al.
J. Lipid Res. 2007;48:1915-1923.
ABSTRACT
| FULL TEXT
Carotid intima-media thickness by B-mode ultrasound as surrogate of coronary atherosclerosis: correlation with quantitative coronary angiography and coronary intravascular ultrasound findings
Amato et al.
Eur Heart J 2007;28:2094-2101.
ABSTRACT
| FULL TEXT
Metabolic Syndrome Increases Operative Mortality in Patients Undergoing Coronary Artery Bypass Grafting Surgery
Echahidi et al.
J Am Coll Cardiol 2007;50:843-851.
ABSTRACT
| FULL TEXT
High-Density Lipoprotein as a Therapeutic Target: A Systematic Review
Singh et al.
JAMA 2007;298:786-798.
ABSTRACT
| FULL TEXT
Chemokine regulation of atherosclerosis
Barlic and Murphy
J. Leukoc. Biol. 2007;82:226-236.
ABSTRACT
| FULL TEXT
Voodoo medicine -- cardiovascular trials jinxed in New Orleans: Dr Anthony Wierzbicki discusses highlights of the 56th Annual Scientific Session of American College of Cardiology held at Morial Conventions Centre in New Orleans March 24th--27th, 2007
Wierzbicki
British Journal of Diabetes & Vascular Disease 2007;7:142-144.
Update on Dyslipidemia
Garg and Simha
J. Clin. Endocrinol. Metab. 2007;92:1581-1589.
ABSTRACT
| FULL TEXT
Effects of reconstituted HDL on charge-based LDL subfractions as characterized by capillary isotachophoresis
Zhang et al.
J. Lipid Res. 2007;48:1175-1189.
ABSTRACT
| FULL TEXT
Prospects for atherosclerosis regression through increase in high-density lipoprotein and other emerging therapeutic targets
Lee and Choudhury
Heart 2007;93:559-564.
ABSTRACT
| FULL TEXT
High-Density Lipoprotein Attenuates Inflammation and Coagulation Response on Endotoxin Challenge in Humans
Birjmohun et al.
Arterioscler. Thromb. Vasc. Bio. 2007;27:1153-1158.
ABSTRACT
| FULL TEXT
Effects of Reconstituted High-Density Lipoprotein Infusions on Coronary Atherosclerosis: A Randomized Controlled Trial
Tardif et al.
JAMA 2007;297:1675-1682.
ABSTRACT
| FULL TEXT
Comparison of Intravascular Ultrasound and Quantitative Coronary Angiography for the Assessment of Coronary Artery Disease Progression
Berry et al.
Circulation 2007;115:1851-1857.
ABSTRACT
| FULL TEXT
Reconstituted High-Density Lipoprotein Stimulates Differentiation of Endothelial Progenitor Cells and Enhances Ischemia-Induced Angiogenesis
Sumi et al.
Arterioscler. Thromb. Vasc. Bio. 2007;27:813-818.
ABSTRACT
| FULL TEXT
Effect of Torcetrapib on the Progression of Coronary Atherosclerosis
Nissen et al.
NEJM 2007;356:1304-1316.
ABSTRACT
| FULL TEXT
Integrated Single-Photon Emission Computed Tomography and Computed Tomography Coronary Angiography for the Assessment of Hemodynamically Significant Coronary Artery Lesions
Rispler et al.
J Am Coll Cardiol 2007;49:1059-1067.
ABSTRACT
| FULL TEXT
Is Intravascular Ultrasound the Gold Standard Surrogate for Clinically Relevant Atherosclerosis Progression?
Brown and Zhao
J Am Coll Cardiol 2007;49:933-938.
ABSTRACT
| FULL TEXT
Different cellular traffic of LDL-cholesterol and acetylated LDL-cholesterol leads to distinct reverse cholesterol transport pathways
Wang et al.
J. Lipid Res. 2007;48:633-645.
ABSTRACT
| FULL TEXT
Biomarkers in the Prevention and Treatment of Atherosclerosis: Need, Validation, and Future
Revkin et al.
Pharmacol. Rev. 2007;59:40-53.
ABSTRACT
| FULL TEXT
High-Density Lipoprotein Cholesterol: An Emerging Target for Stroke Treatment
Sanossian et al.
Stroke 2007;38:1104-1109.
ABSTRACT
| FULL TEXT
A Unique Protease-sensitive High Density Lipoprotein Particle Containing the Apolipoprotein A-IMilano Dimer Effectively Promotes ATP-binding Cassette A1-mediated Cell Cholesterol Efflux
Favari et al.
J. Biol. Chem. 2007;282:5125-5132.
ABSTRACT
| FULL TEXT
Statins, High-Density Lipoprotein Cholesterol, and Regression of Coronary Atherosclerosis
Nicholls et al.
JAMA 2007;297:499-508.
ABSTRACT
| FULL TEXT
Effects of human apolipoprotein A-I on endotoxin-induced leukocyte adhesion on endothelial cells in vivo and on the growth of Escherichia coli in vitro
Thaveeratitham et al.
Innate Immunity 2007;13:58-64.
ABSTRACT
Coronary Artery Calcification and Changes in Atheroma Burden in Response to Established Medical Therapies
Nicholls et al.
J Am Coll Cardiol 2007;49:263-270.
ABSTRACT
| FULL TEXT
Atherosclerosis Regression, Vascular Remodeling, and Plaque Stabilization
Klein
J Am Coll Cardiol 2007;49:271-273.
FULL TEXT
Inhibition of CETP as a novel therapeutic strategy for reducing the risk of atherosclerotic disease
Shah
Eur Heart J 2007;28:5-12.
ABSTRACT
| FULL TEXT
Plant sterol or stanol esters retard lesion formation in LDL receptor-deficient mice independent of changes in serum plant sterols
Plat et al.
J. Lipid Res. 2006;47:2762-2771.
ABSTRACT
| FULL TEXT
Detection and Treatment of Vulnerable Plaques and Vulnerable Patients: Novel Approaches to Prevention of Coronary Events
Waxman et al.
Circulation 2006;114:2390-2411.
FULL TEXT
Structural Analysis of Nanoscale Self-Assembled Discoidal Lipid Bilayers by Solid-State NMR Spectroscopy
Li et al.
Biophys. J 2006;91:3819-3828.
ABSTRACT
| FULL TEXT
Reply
Nicholls et al.
J Am Coll Cardiol 2006;48:1915-1916.
FULL TEXT
Bone Marrow Transplantation Shows Superior Atheroprotective Effects of Gene Therapy With Apolipoprotein A-I Milano Compared With Wild-Type Apolipoprotein A-I in Hyperlipidemic Mice
Wang et al.
J Am Coll Cardiol 2006;48:1459-1468.
ABSTRACT
| FULL TEXT
HDL and the progression of atherosclerosis: new insights
Sirtori
Eur Heart J Suppl 2006;8:F4-F9.
ABSTRACT
| FULL TEXT
Reducing risk by raising HDL-cholesterol: the evidence
Drexel
Eur Heart J Suppl 2006;8:F23-F29.
ABSTRACT
| FULL TEXT
Complex Genetic Architecture Revealed by Analysis of High-Density Lipoprotein Cholesterol in Chromosome Substitution Strains and F2 Crosses
Stylianou et al.
Genetics 2006;174:999-1007.
ABSTRACT
| FULL TEXT
Homocysteine and Cardiovascular Disease: Is HDL the Link?
Barter and Rye
Circ. Res. 2006;99:565-566.
FULL TEXT
Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis
Kontush and Chapman
Pharmacol. Rev. 2006;58:342-374.
ABSTRACT
| FULL TEXT
Optimal Blood Pressure Levels in Patients With Coronary Artery Disease
Tobis and Fonarow
J Am Coll Cardiol 2006;48:839-840.
FULL TEXT
Effects of Normal, Pre-Hypertensive, and Hypertensive Blood Pressure Levels on Progression of Coronary Atherosclerosis
Sipahi et al.
J Am Coll Cardiol 2006;48:833-838.
ABSTRACT
| FULL TEXT
Believability of clinical trials: A diagnostic testing perspective.
Lauer
J. Thorac. Cardiovasc. Surg. 2006;132:249-251.
FULL TEXT
Thematic review series: Patient-Oriented Research. Imaging atherosclerosis: state of the art
Crouse
J. Lipid Res. 2006;47:1677-1699.
ABSTRACT
| FULL TEXT
Intravascular Ultrasound in Cardiovascular Medicine
Nicholls et al.
Circulation 2006;114:e55-e59.
FULL TEXT
Compensatory enlargement of human coronary arteries during progression of atherosclerosis is unrelated to atheroma burden: serial intravascular ultrasound observations from the REVERSAL trial
Sipahi et al.
Eur Heart J 2006;27:1664-1670.
ABSTRACT
| FULL TEXT
Vascular Biomarkers and Surrogates in Cardiovascular Disease
Tardif et al.
Circulation 2006;113:2936-2942.
ABSTRACT
| FULL TEXT
Lipoprotein Metabolism: A Well-Tried Tool to Characterize Dyslipidemic Mechanisms.
Berglund
Arterioscler. Thromb. Vasc. Bio. 2006;26:1201-1203.
FULL TEXT
Macrophage Reverse Cholesterol Transport: Key to the Regression of Atherosclerosis?
Cuchel and Rader
Circulation 2006;113:2548-2555.
FULL TEXT
Inflammation in Atherosclerosis: Some Thoughts About Acute Coronary Syndromes
Lucas et al.
Circulation 2006;113:e728-e732.
FULL TEXT
Mass kinetics of apolipoprotein A-I in interstitial fluid after administration of intravenous apolipoprotein A-I/lecithin discs in humans
Hovorka et al.
J. Lipid Res. 2006;47:975-981.
ABSTRACT
| FULL TEXT
Pathogenesis of atherosclerosis.
Falk
J Am Coll Cardiol 2006;47:C7-C12.
ABSTRACT
| FULL TEXT
Can a Potent Statin Actually Regress Coronary Atherosclerosis?
Blumenthal and Kapur
JAMA 2006;295:1583-1584.
FULL TEXT
Effect of Very High-Intensity Statin Therapy on Regression of Coronary Atherosclerosis: The ASTEROID Trial
Nissen et al.
JAMA 2006;295:1556-1565.
ABSTRACT
| FULL TEXT
The Changing Face of Dyslipidemia Therapies
Rochester and Cooke
Journal of Pharmacy Practice 2006;19:79-93.
ABSTRACT
High density lipoproteins bind A{beta} and apolipoprotein C-II amyloid fibrils
Wilson et al.
J. Lipid Res. 2006;47:755-760.
ABSTRACT
| FULL TEXT
Effect of ACAT inhibition on the progression of coronary atherosclerosis.
Nissen et al.
NEJM 2006;354:1253-1263.
ABSTRACT
| FULL TEXT
Failure of ACAT inhibition to retard atherosclerosis.
Fazio and Linton
NEJM 2006;354:1307-1309.
FULL TEXT
Association of a Model Class A (Apolipoprotein) Amphipathic {alpha} Helical Peptide with Lipid: HIGH RESOLUTION NMR STUDIES OF PEPTIDE{middle dot}LIPID DISCOIDAL COMPLEXES
Mishra et al.
J. Biol. Chem. 2006;281:6511-6519.
ABSTRACT
| FULL TEXT
Relationship Between Atheroma Regression and Change in Lumen Size After Infusion of Apolipoprotein A-I Milano
Nicholls et al.
J Am Coll Cardiol 2006;47:992-997.
ABSTRACT
| FULL TEXT
Distance from the ostium as an independent determinant of coronary plaque composition in vivo: an intravascular ultrasound study based radiofrequency data analysis in humans
Valgimigli et al.
Eur Heart J 2006;27:655-663.
ABSTRACT
| FULL TEXT
Emerging Therapies Targeting High-Density Lipoprotein Metabolism and Reverse Cholesterol Transport
Duffy and Rader
Circulation 2006;113:1140-1150.
FULL TEXT
Crystal structure of human apolipoprotein A-I: Insights into its protective effect against cardiovascular diseases
Ajees et al.
Proc. Natl. Acad. Sci. USA 2006;103:2126-2131.
ABSTRACT
| FULL TEXT
Human apoA-I expression in CETP transgenic rats leads to lower levels of apoC-I in HDL and to magnification of CETP-mediated lipoprotein changes
Masson et al.
J. Lipid Res. 2006;47:356-365.
ABSTRACT
| FULL TEXT
Elevated Markers of Endothelial Dysfunction Predict Type 2 Diabetes Mellitus in Middle-Aged Men and Women From the General Population
Thorand et al.
Arterioscler. Thromb. Vasc. Bio. 2006;26:398-405.
ABSTRACT
| FULL TEXT
Effect of Intensive Versus Standard Lipid-Lowering Treatment With Atorvastatin on the Progression of Calcified Coronary Atherosclerosis Over 12 Months: A Multicenter, Randomized, Double-Blind Trial
Schmermund et al.
Circulation 2006;113:427-437.
ABSTRACT
| FULL TEXT